Inhibitor of angiotensin-converting enzyme modifies myointimal origin in an arterial autograft model

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 2, 1996, Pages 285-293

  Buján, Julia ^a   Bellón, Juan M ^a   Jurado, Francisca ^a   Dominguez, Belén ^a   Gimeno, Maria José ^a   García Honduvilla, Natalio ^a   Hernando, Alvaro ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Angiotensin; Arterial autograft; Cilazapril; Endothelium; Intimal hyperplasia

Indexed keywords

ANGIOTENSIN; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOGRAFT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GRAFT SURVIVAL; ILIAC ARTERY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THROMBOGENESIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIES; CELL DIVISION; CILAZAPRIL; FEMALE; HYPERPLASIA; LEUKOCYTES; MICROSCOPY, ELECTRON; MICROSURGERY; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029780777     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199608000-00016     Document Type: Article

References (43)

1. Clowes AW. Intimal hyperplasia and graft failure. Cardiovasc Pathol 1993;2(suppl):S179-86.
2. Reidy MA, Fingerle J, Lindner V. Factors controlling the development of arterial lesionns after injury. Circulation 1992;86(suppl III):III43-6.
3. Arnal JF, Battle T, Rasetti C, et al. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 1994;267:H1777-84.
4. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995;95:1353-62.
5. 125I labelled angiotensin I in isolated perfused porcine coronary and carotid arteries. Cardiovascular Res 1995;29:789.
6. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992;19:753-7.
7. Jaiswall N, Diz DI, Chappell MC, Khosla MC, Ferrario CM. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors. Hypertension 1992;19(suppl II):II49-55.
8. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987;59:59-65A.
9. Rogerson FM, Chai SY, Schlawe I, Murray WK, Marley PD, Mendelsohn FA. Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens 1992;10:615-20.
10. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-6.
11. Ko Y, Stiebler H, Nickenig G, Wieczorek AJ, Vetter H, Sachinidis A. Synergistic action of angiotensin II, insulin-like growth factor-I. and transforming growth factor-β on platelet-derived growth factor-BB, basic fibroblast growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Am J Hypertens 1993;6:496-9.
12. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989;13:305-14.
13. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990;15:68-77.
14. Itoh H, Pratt RE, Gibbons G, Dzau VJ. Angiotensin-II modulates proliferation of vascular smooth-muscle cells (VSMC) via dual autocrine loops of TGF-β and bFGF. Hypertension 1991;18:396.
15. Powell JS, Clozel JP, Müller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
16. Powell JS, Müller RKM, Rouge M, Kuhn H, Hefti F, Baumgartner HR. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 1990;16(suppl 4):S42-9.
17. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994;93:339-46.
18. Fishel RS, Thourani V, Eisenber SJ, et al. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury. J Clin Invest 1995;95:377-87.
19. Owens GK. Differential effects of antihypertensive drug therapy on vascular smooth cell hypertrophy, hyperploidy and hyperplasia in the spontaneously hypertensive rat. Circ Res 1985;56:525-36.
20. Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173-8.
21. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-77.
22. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
23. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
24. Farhy RD, Ho KL, Carretero OA, Scicli AG. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992;182:283-8.
25. Kühberger E, Groschner K, Kukovetz WR, Brunner F. The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery. Br J Pharmacol 1994;113:1289-94.
26. Linz W, Wiemer G, Schölkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 1993;22(suppl 9):S1-8.
27. Farhy RD, Carretero OA, Ho KL, Scili AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 1993;72:1202-10.
28. Clozel JP, Hess P, Schietinger K, Breu V, Fischli W, Baumgartner HR. Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs. Life Sci 1994;54:PL87-92.
29. Rakugi H, Wang DS, Dzau VJ, Pratt RE. Potencial importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 1994;90:449-55.
30. Schwartz RS. Neointima and arterial injury: dogs, rats, pigs, and more. Lab Invest 1994;71:789-91.
31. Buján J, Bellón JM, Gianonatti MC, Golitsin A. Intimal thickening in arterial autografts. Role of the adventitial layer. Histol Histopathol 1992;7:189-97.
32. Lam JYT, Lacoste L, Bourassa MG. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation 1992;85:1542-7.
33. Clozel JP, Hess P, Michael C, Schietinger K, Baumgartner HR. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension 1991;18(suppl II):II55-9.
34. Bell L, Madri JA. Influence of angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990;137:7-12.
35. Clozel M, Kuhn H, Baumgartner HR. ACE inhibition and the vascular intima in hypertension. J Cardiovasc Pharmacol 1993;22(suppl 4);S15-8.
36. 1 receptor antagonist. Am J Pathol 1991;139:1291-6.
37. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte-macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension 1991;18:132-41.
38. Romo M, Auvinen J, Hirvonen H, Pitkämäki L, Pynnönen S, Saarinen P. Effect of cilazapril on lipids. Am J Med 1993;94(suppl 4):S53-5.
39. Varty K, Allen KE, Jones L, Sayers RD, Bell PRF, London NJM. Influence of losartan, an angiotensin receptor antagonist, on neointimal proliferation in cultured human saphenous vein. Br J Surg 1994;81:819-22.
40. Plissonnier D, Amichot G, Duriez M, Legagneux J, Levy BI, Michel JB. Effect of converting enzyme inhibition on allograft-induced arterial wall injury and response. Hypertension 1991;18(suppl II):II47-54.
41. Roux SP, Clozel JP, Kuhn H. Cilazapril inhibits wall thickening of vein bypass graft in the rat. Hypertension 1991;18 (suppl II):II43-6.
42. Hanson SR, Powell JS, Dodson T, et al. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 1991;18(suppl II):II70-6.
43. Hirko MK, McShannic JR, Sharp WV. Pharmacologic modulation of intimal hyperplasia in canine interposition grafts. J Vase Surg 1992;16:472-3.